Immune Pressure? Sporozoite Vaccine Candidate, Selected by Circumsporozoite Antigen, a Leading Plasmodium falciparum in the Are Extensive T Cell Epitope Polymorphisms
暂无分享,去创建一个
L. Rénia | N. Lebrun | N. White | G. Snounou | P. Singhasivanon | S. Khusmith | A. Alloueche | A. Brockman | S. Looareesuwan | C. Hirunpetcharat | F. Nosten | C. Kumkhaek | A. Grüner | Kooruethai Phra-ek
[1] Inacio Mandomando,et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial , 2004, The Lancet.
[2] L. Rénia,et al. A survey of the Th2R and Th3R allelic variants in the circumsporozoite protein gene of P. falciparum parasites from western Thailand. , 2004, The Southeast Asian journal of tropical medicine and public health.
[3] A. Hill,et al. A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease , 2004, Nature Medicine.
[4] L. Rénia,et al. Pre-erythrocytic antigens of Plasmodium falciparum: from rags to riches? , 2003, Trends in parasitology.
[5] D. Conway,et al. Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific. , 2003, The American journal of tropical medicine and hygiene.
[6] S. Kariuki,et al. A study of genetic diversity in the gene encoding the circumsporozoite protein (CSP) of Plasmodium falciparum from different transmission areas--XVI. Asembo Bay Cohort Project. , 2002, Molecular and biochemical parasitology.
[7] D. Conway,et al. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial , 2001, The Lancet.
[8] D. Conway,et al. High-throughput sequence typing of T-cell epitope polymorphisms in Plasmodium falciparum circumsporozoite protein. , 2000, Molecular and biochemical parasitology.
[9] T. McCutchan,et al. The Cytotoxic T-Lymphocyte Epitope of the Plasmodium falciparum Circumsporozoite Protein Also Modulates the Efficiency of Receptor-Ligand Interaction with Hepatocytes , 2000, Infection and Immunity.
[10] M. Plebanski,et al. Induction of CD8+ T cells using heterologous prime‐boost immunisation strategies , 1999, Immunological reviews.
[11] W. Jarra,et al. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[12] K. Kain,et al. Differential Susceptibilities of Anopheles albimanus and Anopheles pseudopunctipennis to Infections with Coindigenous Plasmodium vivaxVariants VK210 and VK247 in Southern Mexico , 1999, Infection and Immunity.
[13] A. Hill,et al. Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. , 1997, Journal of immunology.
[14] R. Ménard,et al. Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes , 1997, Nature.
[15] R. Paru,et al. Mating patterns in malaria parasite populations of Papua New Guinea. , 1995, Science.
[16] A. Hughes,et al. Allelic variation in the circumsporozoite protein of Plasmodium falciparum from Thai field isolates. , 1994, The American journal of tropical medicine and hygiene.
[17] V. Nussenzweig,et al. Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes , 1993, The Journal of experimental medicine.
[18] D. Doolan,et al. Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development , 1992, Infection and immunity.
[19] V. Nussenzweig,et al. Plasmodium falciparum: restricted polymorphism of T cell epitopes of the circumsporozoite protein in Brazil. , 1990, Experimental parasitology.
[20] C. Newbold,et al. Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein. , 1989, Molecular and biochemical parasitology.
[21] T. McCutchan,et al. Polymorphism in the circumsporozoite (CS) protein of Plasmodium falciparum. , 1989, Parasitology today.
[22] V. Nussenzweig,et al. Rationale for the development of an engineered sporozoite malaria vaccine. , 1989, Advances in immunology.
[23] M. J. Stewart,et al. Malaria sporozoites leave behind trails of circumsporozoite protein during gliding motility. , 1988, The Journal of protozoology.
[24] J. Berzofsky,et al. Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[25] L. Miller,et al. The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation. , 1988, Immunology today.
[26] L. Rozeboom,et al. On the Comparative Susceptibility of Certain Species of Nearctic and Neotropical Anophelines to Certain Strains of P. Vivax and P. Falciparum from the Same Regions1 , 1938 .
[27] S. P. James,et al. A Study of Induced Malignant Tertian Malaria , 1932, The Indian medical gazette.